Pursuant to Regulation 33 of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, we are submitting herewith Unaudited Standalone and Consolidated Financial REsults for the half year ended 30th September 2024.
Sudarshan Pharma Industries - Financial Results For The Half Year Ended 30Th September 2024
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Sudarshan Pharma Industries Ltd on 6ix
Later from Sudarshan Pharma Industries
- Fixation Of November 18, 2024 As Record Date For The Purpose Of Sub-Division/Split Of Face Value Of Equity Shares Of The Company.
- Sudarshan Pharma Industries Ltd Press Release Nov 07 2024
- Revised Record Date I.E. November 23, 2024 For The Purpose Of Sub-Division/ Split Of Shares Of The Company
- Sudarshan Pharma Industries Ltd Press Release Nov 08 2024
- Addendum To The Notice Of The Extraordinary General Meeting Of Sudarshan Pharma Industries Limited Held On Monday, 30Th September, 2024
Follow Sudarshan Pharma Industries into a list and get an email when it puts out news.
Follow Sudarshan Pharma Industries